This video is featured in the 2024 ASCO® Annual Meeting Insights Hub

2024 ASCO® Annual Meeting Insights Hub
T

ASCO® 2024 Insights: "Atezolizumab & Varlilumab (CDX-1127) +/- Cobimetinib in Previously Treated Unresectable Biliary Tract Cancer"

By 2024 ASCO® Annual Meeting Insights Hub FEATURING Thatcher Heumann
By 2024 ASCO® Annual Meeting Insights Hub FEATURING Thatcher Heumann
36 views
June 12, 2024
0 Comments
Login to view comments. Click here to Login

2024 ASCO® Annual Meeting Insights Hub: GI Videos

2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Insights: "Botensilimab + Balstilimab in Microsatell…

Feat. A. Bullock
12:27
2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Insights: "Biomarker-Directed Treatment for Pancreat…

Feat. J. Knox
12:29
2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Summary: "Fruquintinib in Refractory mCRC"

Feat. C. Eng
View All

Related Content

AUTOPLAY
57:44
Vogl, NY

Vogl,NY on How to Ask Good Questions at Medical Meetings

Feat. S. Vogl
17:50
AdventHealth

Clinical Highlights From AACR 2024: Trials Evaluating Selected New T…

Feat. G. Sonpavde
27:04
Fengting Yan

Cancer Screening Molecular Tools

22:55
Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Summary: "GI Key Studies Including PROSPECT, HERIZON…

Feat. R. Kim, R. Mehta
29:25
Northwestern Medicine Oncology and Hematology

Hyperprogression in Cancer Treated With Immunotherapy

Feat. Y. Chae
27:37
ASCO GI 2023 Conference Coverage

ASCO GI 2023 Expert Panel Discussion: Practice-Changing Updates

Feat. N. Uboha, A. Turk, K. Spencer, M. Cecchini
22:33
Integrity CE

Oligometastatic Colon Cancer to Liver: Case Presentation and Panel D…

Feat. V. Lee, R. Kumar, N. Bhagat, E. Winslow
06:47
UCSF School of Medicine

Tumor-Agnostic Efficacy & Safety of Selpercatinib in RET Fusion+…

Feat. H. Kang
07:27
Jason Levy

Opus One: Final Results - RFA in Axial Skeleton

28:25
Integrity CE

Extensive, Liver-Only Metastases From Colon Cancer: Case Presentatio…

Feat. V. Lee, E. Christenson, N. Bhagat, E. Winslow
16:40
Moffitt Cancer Center

Year in Review: Hepatobiliary Cancers

Feat. R. Kim, T. Biachi
13:47
Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Insights: "Expanding the Benefit - Dabrafenib/Tramet…

Feat. V. Subbiah
06:03
Total Health

2024 Updates on Targeted Approaches for GI Cancers and New Data in N…

Feat. A. Grothey
09:03
Integrity CE

Combined Hepatocellular-Cholangiocarcinoma: Diagnosis and Management

Feat. J. Birkness-Gartman
08:24
Yale Cancer Center

GI Oncology Year in Review: Hepatobiliary Cancers

Feat. P. Kunz
12:04
Arndt Vogel

Pemigatinib in Cholangiocarcinoma: Targeting FGFR2 Fusions

15:24
Horizon CME

MRD in GI Malignancies: Current Clinical Utility of ctDNA

Feat. A. Scott
14:33
Insights from 2023 ESMO Annual Meeting

Personalized Medicine and Targeted Agents for Biliary Tract Cancer

Feat. L. Rimassa
15:49
Integrity CE

Updates in Targeted Therapies for Metastatic Biliary Tract Cancers

Feat. J. Harding
21:46
Insights from 2023 ESMO Asia Annual Meeting

ESMO Asia 2023 Insights: "Past, Present & Future Clinical M…

Feat. M. Ikeda